The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Open accessAbstract
Background & Aims Patients with hepatitis C virus (HCV) infection are at risk for developing additional liver disorders that are costly to treat and have high rates of morbidity, although the actual prevalence of these diseases is not known. We examined time trends in the prevalence of cirrhosis and its related complications, such as hepatic decompensation and hepatocellular cancer (HCC). Methods We calculated the annual prevalence of cirrhosis, decompensated cirrhosis, and HCC in a national sample of veterans diagnosed with HCV between 1996 and 2006. Patients with HCV who had at least 1 physician visit in a given calendar year were included in the analysis of prevalence for that year. We used direct standardization to adjust the prevalence of cirrhosis and related complications for increasing age of the cohort, as well as sex and changes in clinical characteristics. Results In this cohort, the number of individuals with HCV increased from 17,261 in 1996 to 106,242 in 2006. The prevalence of cirrhosis increased from 9% in 1996 to 18.5% in 2006. Similarly, the prevalence of patients with decompensated cirrhosis doubled, from 5% in 1996 to 11% in 2006, whereas the prevalence of HCC increased approximately 20-fold (0.07% in 1996 to 1.3% in 2006). After adjustment, the time trend in the prevalence of cirrhosis (and its complications) was lower than the crude trend, although it still increased significantly. Conclusions The prevalence of cirrhosis and HCC in HCV-infected patients has increased significantly over the past 10 years, and could increase further. An aging cohort of HCV patients could partly explain our findings. Clinicians and healthcare systems should develop strategies to provide timely and effective care to this high-risk population of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
American Association for the Study of Liver Diseases
Popper, H. (1960) · Gastroenterology · doi:10.1016/s0016-5085(60)80094-7 · Cited by 903
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Self-citationRates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell-Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 672
Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290235 · Cited by 659
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Projecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 576
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C
Falck-Ytter, Y., Kale, H., Mullen, K. D., Sarbah, S. A., Sorescu, L., & McCullough, A. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00008 · Cited by 301
KRAMER, J. R., DAVILA, J. A., MILLER, E. D., RICHARDSON, P., GIORDANO, T. P., & EL‐SERAG, H. B. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03572.x · Cited by 268
Self-citationChanging trends in hepatitis C–related mortality in the United States, 1995‐2004†‡
Wise, M., Bialek, S., Finelli, L., Bell, B. P., & Sorvillo, F. (2008) · Hepatology · doi:10.1002/hep.22165 · Cited by 229
Predictors of response of U.S. veterans to treatment for the hepatitis C virus
Backus, L. I., Boothroyd, D. B., Phillips, B. R., & Mole, L. A. (2007) · Hepatology · doi:10.1002/hep.21662 · Cited by 225
THE EPIDEMIOLOGY OF ACUTE AND CHRONIC HEPATITIS C
Alter, M. J. (1997) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70321-4 · Cited by 211
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers
Dominitz, J. A., Boyko, E. J., Koepsell, T. D., Heagerty, P. J., Maynard, C., & Sporleder, J. L. (2005) · Hepatology · doi:10.1002/hep.20502 · Cited by 209
Harris, D. R., Gonin, R., Alter, H. J., Wright, E. C., Buskell, Z. J., Hollinger, F. B., Seeff, L. B., & for the National Heart, L. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00012 · Cited by 194
Diabetes increases the risk of acute hepatic failure
El–Serag, H. B., & Everhart, J. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.33650 · Cited by 174
Self-citationHepatitis C infection in African Americans: its natural history and histological progression
Wiley, T. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04117-x · Cited by 169
Hepatitis C and human immunodeficiency virus infection
Thomas, D. L. (2002) · Hepatology · doi:10.1053/jhep.2002.36380 · Cited by 144
Julapalli, V. R., Kramer, J. R., & El‐Serag, H. B. (2005) · Liver Transplantation · doi:10.1002/lt.20434 · Cited by 122
Self-citationKanwal, F., Hoang, T., Spiegel, B. M. R., Eisen, S. A., Dominitz, J. A., Gifford, A. L., Goetz, M. B., & Asch, S. M. (2007) · Hepatology · doi:10.1002/hep.21927 · Cited by 120
Self-citationUtilization of Screening for Hepatocellular Carcinoma in the United States
Davila, J. A., Weston, A., Smalley, W. E., & El‐Serag, H. B. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3180381560 · Cited by 113
Self-citationBackus, L. I., Gavrilov, S., Loomis, T. P., Halloran, J. P., Phillips, B. R., Belperio, P. S., & Mole, L. A. (2009) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m3203 · Cited by 104
Progression of fibrosis in chronic liver diseases: time to tally the score
Pinzani, M., Romanelli, R. G., & Magli, S. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00055-1 · Cited by 70
Coinfection by hepatitis B virus and hepatitis C virus.
Pontisso, P., Gerotto, M., Benvegnù, L., Chemello, L., & Alberti, A. (1998) · PubMed · Cited by 63
Tsai, J., Jeng, J., Ho, M., Chang, W., Lin, Z., & Tsai, J. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80004-3 · Cited by 51
Population-based hepatitis C surveillance and treatment in a national managed care organization.
Shatin, D., Schech, S. D., Patel, K., & McHutchison, J. G. (2004) · PubMed · Cited by 48
Cited by
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,070
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Self-citationDaclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
Epidemiology of Hepatocellular Carcinoma: Consider the Population
Mittal, S., & El-Serag, H. B. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182872f29 · Cited by 1,076
Self-citation
Metadata
- Authors
- Kanwal, F., Hoang, T., Kramer, J. R., Asch, S. M., Goetz, M. B., Zeringue, A., Richardson, P., & El–Serag, H. B.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 140
- Issue
- 4
- Pages
- 1182-1188.e1
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2097232234
- Cited by
- 395
- References
- 32
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.